You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

February 20, 2013

Local Distributor Partnerships: Investigate Before You Terminate

Informed Counsel

Foreign companies usually opt to appoint their local distributors as the local entity to apply for and maintain product registration and import licenses, as usually required by Asian FDAs and Ministries of Agriculture. Such appointments are normally set out in the distribution agreement. While on most occasions this is a mutually beneficial relationship, sometimes local partners who have built up the business for those products may begin to compete unfairly or commit other breaches that lead to difficulties in terms of terminating a partner.

Determination of Acceptable Breach

All commercial relationships have their ups and downs, which may not reach a level of acceptable breach to warrant a termination. Economic turndowns, weather conditions, increased competition, and other situations are all reasonable events whereby you and your local partner may need to reposition and revisit minimum sales targets and advertising spend. However, as soon as relations appear unstable and reports of unsatisfactory performance start coming in regularly, the foreign partner should look closely into the conduct of its local partner in order to head off what may amount to warranted termination.

Simple searching will reveal that your partner is disregarding your agreement. The distribution agreement likely has a clause allowing you to visit, unannounced, to inspect. In other circumstances, checks like this can also be made at the relevant Companies Registry, Ministry of Commerce, tax office, etc.

Frequently observed examples of breaches are:

  • Registration of a similar trademark for an identical product
  • Manufacture and/or sale of a competitive product without authorization
  • Non-observance of the target without any reasons or notification given
  • Conspicuous decrease in sales of some products while maintaining adequate sales of others

Agreement Review

Your next step is to go through the terms of your agreement with the partner carefully to determine whether these infringements may amount to a material breach, and to pinpoint the consequences for such breaches or infringements.

Another important step is to clearly check the dispute resolution and termination process in the agreement. You may find that arbitration is the stated dispute resolution procedure or that there has been a carve out for court injunctive relief on the occurrence of IP infringement. In the latter case, you can go to court immediately to seek an injunction.

You must check whether termination is effective immediately or after a prescribed period of time. If there is a breach, the termination process should be clearly followed, as the local partner may deny any wrongdoing on his or her part. Here, your paper trail of earlier warnings will be very helpful.

Notification Before the Termination

The termination notice should:

  • Include a list of all breaches in order to reduce the chance of the distributor thinking he or she can challenge the allegations
  • Be carefully worded
  • List all documents to be returned for a clear termination of the relationship, including the Certificate of Free Sale and cancellation of the Import License, in order to discourage your local partner from pursuing further unauthorized sales

When the situation with a breaching distributor has passed the point of no return, you have to check the name under which products were registered. In Thailand, products are required to be registered in the name of a local entity.

An amendment of the application is not possible and the foreign company has to reapply to obtain a new product registration certificate. The advantage of this method is that the local partner may not be aware of such new applications. The inconvenience is that it may take a few months before the new Product Certificate is granted, costs will be incurred, and sometimes retesting is required.

It is in the interest of the foreign company to finalize the complete process and change to a new distributor as soon as the termination is effective. However, you should first check whether an application for the same product is contrary to the terms of your agreement, especially in regard to anticompetition rules or exclusivity granted to the distributor.


Compliance Audit

A Compliance Audit is normally advised either during the course of or immediately after regulatory complaints. Compliance Audits are conducted by a team of lawyers and/or paralegals visiting local offices in order to review, collect, and assess those areas of the business that are susceptible to additional regulatory scrutiny. Typically, a Compliance Audit would encompass review of:

  1. Advertising and promotional materials (past, current, and planned)
  2. Product labels, product inserts, and product packaging (past, current, and planned)
  3. Thai FDA product registration certificates
  4. Customer complaint procedures
  5. Organizational structure
  6. Other areas as observed during the course of the Compliance Audit

A Compliance Audit is usually conducted in about one day. Findings are assessed in order to prepare the Compliance Audit Report. The Compliance Audit Report aims to assist with effecting policies and procedures to confirm continual compliance with evolving legislation and regulations. This Report sets out the practical advice and suggested strategies to identify how current processes, policies, procedures, legal agreements, and practice could be supplemented to minimize and manage the types of risks the business is currently dealing with. The investment required to conduct a full-day assessment visit and develop the follow-up Compliance Audit Report depends on several factors including (1) the level of cooperation with your local company, (2) the amount of documentation requiring assessment as discovered during the assessment visit, and (3) the scope of the review in terms of how many years of business we think necessary to include in our assessment. By knowing what risks remain and by formulating and implementing effective procedures and policies to end these, business vulnerability can be decreased significantly.

RELATED INSIGHTS​ 

August 10, 2026
On June 17, 2026, Indonesia’s National Agency of Drug and Food Control (BPOM) issued BPOM Regulation No. 10 of 2026 on Nutritional Information on Processed Food Labels. The new regulation, which revokes three previous nutrition labeling regulations, introduces several notable changes affecting food and beverage manufacturers, importers, and distributors. These changes range from updated nutrient reference values and serving-size requirements to the introduction of the Nutri-Level front-of-pack labeling system for certain beverage products. Businesses operating in Indonesia should carefully review these developments and assess their products’ compliance with the new requirements during the transition period. Implementation of the Nutri-Level Labeling System To implement the recently issued decree on Nutri-Level labeling, BPOM Regulation No. 10 of 2026 stipulates the requirements to implement the Nutri-Level labeling system on the front-of-pack. Under the new framework, ready-to-drink beverages, powdered beverages, and liquid or solid concentrates are required to display Nutri-Level labeling on the front label of their packaging. The Nutri-Level labeling system classifies products into color-coded levels A through D based on their sugar, sodium, and total fat content. The applicable Nutri-Level is determined based on the lowest level measured in the assessment of sugar, sodium, and total fat content. For products classified as level C or D, the Nutri-Level label must be accompanied by information on the relevant sugar, sodium, and total fat content per 100 ml of the ready-to-consume product. Products classified as level A or B may either display only the Nutri-Level designation or display the Nutri-Level together with the relevant nutritional information per 100 ml. Minimum Vitamin and Mineral Content Required for Declaration BPOM Regulation No. 10 of 2026 introduces a stricter threshold for the declaration of vitamins and minerals in the nutritional value information section (ING). Vitamins or minerals may only be declared if they are present at a
August 10, 2026
The drug registration process in Vietnam will be simplified, particularly for foreign applicants, following the recent issuance by Vietnam’s Ministry of Health (MOH) of a new circular that is expected to reduce administrative hurdles. Circular No. 32/2026/TT-BYT on the registration of drugs and medicinal ingredients (Circular 32) was issued on July 29, 2026, and will take effect on October 1, 2026, replacing Circular No. 12/2025/TT-BYT. Key provisions of the new circular are discussed below. Five-Year Data Exclusivity and Five-Month Public Disclosure Framework Circular 32 updates data protection guidelines by explicitly referencing Article 128 of the amended Intellectual Property Law, which sets out that new drugs supported by clinical trial data submitted for the first time will be granted a five-year data exclusivity period from the date of the initial marketing authorization (MA) approval. Subsequent applications that rely on the originator’s protected data will not be eligible for approval from the date of submission of the originator’s registration dossier until five years after the first MA is granted. Furthermore, in accordance with the new regulations, the regulatory authority must publicly disclose information on subsequent applications five months before the granting of MA, providing originator companies with an opportunity to exercise and enforce their intellectual property rights. Simplified Requirements for Foreign Legal Documents Circular 32 expands the circumstances under which legal documents issued by foreign authorities are exempt from consular legalization and authenticity verification requirements. Specifically, such documents may be exempt if the Drug Administration of Vietnam (DAV) is able to verify their authenticity directly through official electronic means, including written confirmation or email correspondence sent directly to the MOH by the competent foreign authority, or publicly accessible English-language databases maintained by recognized foreign regulatory authorities. In addition, the new circular permits the submission of electronic notarized copies of legal documents
July 24, 2026
As food innovation continues to accelerate, manufacturers are increasingly introducing ingredients derived from new sources, produced using novel technologies, or lacking a significant history of human consumption. While these innovations create new opportunities for the food industry, they also raise important questions regarding consumer safety. For this reason, many jurisdictions, including Thailand, the European Union, Australia and New Zealand, Canada, and Singapore, require a premarket safety assessment for novel food ingredients before they can be placed on the market. The objective of this assessment is to ensure that each ingredient is safe for its intended use and level of consumption, does not present toxicological, allergenic, microbiological, or nutritional concerns, and will not mislead consumers. Scientific authorities typically evaluate the ingredient’s identity, manufacturing process, composition, specifications, anticipated dietary exposure, toxicological information, nutritional impact, and history of use before determining whether it can be marketed. Against this background, the Thai Food and Drug Administration (FDA) recently took an important step toward improving regulatory transparency by publishing, for the first time, a consolidated public list of substances that have successfully completed the Thai FDA’s safety assessment process, including substances determined to be novel foods and those determined not to fall within the novel food category. The list identifies the approved substances, the corresponding manufacturers or importers, approval dates, and the approved conditions of use. Although the publication does not change the existing legal framework governing novel food approvals, it provides businesses with greater visibility into the Thai FDA’s regulatory precedents and the types of substances that have previously been accepted through the safety assessment process. The full announcement is available on the Thai FDA’s website. As the list is now publicly available, it also provides useful insight into the types of substances that have successfully completed the Thai FDA’s safety assessment process.
July 24, 2026
For businesses in Thailand’s regulated industries, the problem of “too many licenses” is one of the most familiar hurdles to getting a product to market. Take a simple example: importing the materials necessary to sell teriyaki chicken skewers. To legally do this, a business may need approvals from several different agencies—separate permits for the chicken (Department of Livestock Development), the dipping sauce (Thai FDA), the wooden skewers (Department of Forestry), and other ingredients, each under a different authority. This kind of overlap is often cited to argue for a “regulatory guillotine”—a systematic review to cut outdated or duplicative rules that slow investment and business activity. The Facilitation of Licensing and Public Service Consideration Act B.E. 2569 (2026) (Licensing Facilitation Act 2026) is Thailand’s most significant response yet to that concern. This article looks at the Facilitation Act 2026 through a life sciences and regulatory affairs lens—what it may mean for the manufacturers, importers, and distributors of food, drugs, medical devices, cosmetics, and similar products who routinely deal with several regulators to bring a single product to market. The Super License: One Approval Standing in for Many The reform with the clearest potential for regulated-product businesses is the law’s “super license” mechanism, referred to as a “main license” in the statute. Once a business obtains the main license for a regulated activity, it is automatically deemed to hold all related sublicenses issued by other agencies for that same activity, provided the activity has been designated as eligible in the Government Gazette. The Licensing Facilitation Act 2026 also creates a central application center, allowing applicants to submit a single application and pay all relevant fees at one point of contact, with the center routing the application to each agency through a shared information system. The potential benefits of this for businesses